Sublingual film containing Dexmedetomidine (BXCL501)

Drug identity checked against registry records

Also recorded as Dexmedetomidine

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar DisorderNCT04276883BioXcel Therapeutics IncPhase 3Completed2020-05-21Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.